Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Profit Margin

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) (SRNGU) currently reports a profit margin of -314.76% as of June 2026. That compares with -136.56% in the prior-year period — down 130.5% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s profit margin history and peer comparisons.

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s profit margin decreased from -136.56% to -314.76% — a 130.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s profit margin of -314.76% is lower than the Healthcare sector average of 13.89%. That is roughly 2366.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s current -314.76% should be judged against Healthcare norms (sector average: 13.89%) and against SRNGU's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -314.76%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War), and consider following SRNGU for alerts when major investors trade the stock.